Hye Ryun Kim
0000-0002-1842-9070
Yonsei Cancer Center
6 papers found
Refreshing results…
A Phase II Open-Label Randomized Clinical Trial of Preoperative Durvalumab or Durvalumab plus Tremelimumab in Resectable Head and Neck Squamous Cell Carcinoma
Assessment of hyperprogression versus the natural course of disease development with nivolumab with or without ipilimumab versus placebo in phase III, randomized, controlled trials
Patient-Derived Cells to Guide Targeted Therapy for Advanced Lung Adenocarcinoma
High CD3 and ICOS and low TIM-3 expression predict favourable survival in resected oesophageal squamous cell carcinoma
Dynamic changes in PD-L1 expression and CD8+ T cell infiltration in non-small cell lung cancer following chemoradiation therapy
Real-World Analysis of the Efficacy of Rebiopsy andEGFRMutation Test of Tissue and Plasma Samples in Drug-Resistant Non-Small Cell Lung Cancer
Missing publications? Search for publications with a matching author name.